Bryn Mawr Trust CO Revolution Medicines, Inc. Transaction History
Bryn Mawr Trust CO
- $5.25 Billion
- Q1 2025
A detailed history of Bryn Mawr Trust CO transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 2,500 shares of RVMD stock, worth $91,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$91,675
Previous $109,000
19.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$609 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$496 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$492 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$432 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$374 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.22B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...